Meanwhile, the results of molecular docking also exposed the active ingredients of YPFG could tack a part in modulating the progression of pneumonia via MMP9, CCL2, IL-1B, IL-6, CXCL8, and TNF. This evidence concerns the gene CXCL8 and pneumonia.